The knock on the company is going stale: this quarter's own facts cut against the standing doubt
The model's full reasoning — Q3 2022 call → NO我们根据提供的财报电话会议记录,分析是否存在一个明确的、公司特定的疑虑,以及本季度的实际运营证据是否明显反驳了该疑虑。 首先,寻找疑虑。电话会议中,管理层多次提到公司正在建设两个大型项目(Waukegan和Chamonix),这些项目是未来的重点。同时,现有业务(如Bronco Billy's、Silver Slipper等)受到各种影响,如竞争、保险成本、食品成本等。但有一个反复出现的主题:公司过去亏损,现在依靠新项目扭转局面。管理层提到“pre-opening costs”影响净收入,但强调这是投资。此外,有分析师问及“return calculus”和“macro perspective”,但疑虑可能在于公司能否成功开业并盈利。 具体看,管理层在回答关于Waukegan开业时间时,强调“we're not going to open until we're confident that we're ready”,并提到“you certainly don't want a flood opening like it has happened at some casinos”。这暗示市场可能担心公司能否顺利开业。但更明显的疑虑可能是:公司长期亏损,新项目能否带来盈利?或者公司依赖新项目,而现有业务在衰退? 在电话会议中,管理层提到“we're spending so much time getting these two new places open, because they really are the future of the company.” 这暗示公司未来依赖新项目。同时,有分析师问及“return calculus”和“macro perspective”,但管理层回答时提到“I kind of feel better than ever”并给出具体数据,如Rivers的业绩、Colorado Springs人口增长等。 但疑虑是否明确?管理层没有直接说“投资者担心我们能否盈利”,但通过回答,可以推断出市场可能担心公司长期亏损。例如,管理层提到“pre-opening costs”影响净收入,但强调这是投资。此外,在回答关于现金和融资时,管理层说“we don't need any money”并提到有备用融资,这可能是回应资金担忧。 然而,更具体的疑虑可能是:公司能否成功开业Waukegan?因为这是关键。但本季度的实际证据是什么?管理层说“The parking lots are paved, lit, striped, the kitchens are in place... The decor is going up on the inside. This week, we'll be rolling out carpet and putting in slot basis and starting to install the slot machines.” 这是实际进展,但这是建设进展,不是运营证据。本季度运营证据方面,管理层提到“In Colorado, we're also making good progress”但具体数字?现有业务方面,管理层提到“Bronco Billy's”因装修关闭了一半,导致亏损,但预计年底重新开放。还有“new competition”等。 但疑虑是否被本季度实际运营证据反驳?管理层提到“property margins”从13.5%提高到25.5%,这是实际改善。但这是对比2019年,不是本季度。本季度具体数字?管理层说“it was an okay quarter, it wasn't a great quarter, it wasn't an awful quarter, operationally.” 这似乎没有明显反驳疑虑。 再仔细看,疑虑可能在于“公司能否从亏损中走出来?”但本季度实际证据是:新项目即将开业,但尚未开业。现有业务有各种问题。所以,本季度实际运营证据并没有明显反驳疑虑,而是管理层在展望未来。 另一个可能的疑虑:公司依赖单一市场或客户?但这里没有。 或者,疑虑是“公司能否成功执行大型项目?”但本季度证据是建设进展,但这是计划内,不是实际运营。 我认为,电话会议中并没有一个明确的、公司特定的疑虑被反复提及。分析师的问题更多是关于开业时间、CapEx、利润率等,但并没有一个“standing knock”如“公司永远无法盈利”或“产品没有需求”等。管理层也没有直接回应一个长期存在的疑虑。 因此,可能没有符合要求的疑虑。所以答案应为NO。 但再检查:管理层提到“we're spending so much time getting these two new places open, because they really are the future of the company.” 这暗示公司过去依赖现有业务,但现有业务在衰退?实际上,现有业务有竞争压力,但管理层说“it was an okay quarter”。没有明确说“投资者担心我们无法盈利”。 或许疑虑是“公司能否在Waukegan成功开业?”但本季度证据是建设进展,但这是计划内,不是实际运营。而且管理层说“we're not going to open until we're confident”,这没有反驳疑虑,而是承认风险。 因此,我认为没有明确的疑虑被本季度实际证据反驳。所以答案NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| IFS | Intercorp Financial Services Inc. | Q1 2024 | 2024-05-14 | C+ |
| PRA | ProAssurance Corporation | Q1 2024 | 2024-05-11 | D |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| ALL | The Allstate Corporation | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| PTN | Palatin Technologies, Inc. | Q4 2023 | 2023-09-29 | D |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| BXSL | Blackstone Secured Lending Fund | Q1 2023 | 2023-05-10 | A |
| FTHM | Fathom Holdings, Inc. | Q1 2023 | 2023-05-10 | C |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| CLSD | Clearside Biomedical, Inc. | Q3 2022 | 2022-11-09 | C |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| EXFY | Expensify, Inc. | Q2 2022 | 2022-08-12 | D |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FARM | Farmer Bros. Co. | Q3 2022 | 2022-05-07 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| GECC | Great Elm Capital Corporation | Q3 2018 | 2018-11-13 | B |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| PII | Polaris Inc. | Q3 2017 | 2017-10-24 | C+ |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| MTG | MGIC Investment Corporation | Q3 2017 | 2017-10-18 | B+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| ULBI | Ultralife Corporation | Q3 2016 | 2016-10-29 | C+ |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
BRX · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible on the call, and if this period's operating evidence cuts against it. YES The standing doubt is the skepticism that tenant disruptions (especially bankruptcies like Bed Bath) will create occupancy pressure and throw markets out of equilibrium, given the recaptured space and potential for more filings. This is visible in analyst questions (Todd Thomas on Bed Bath impact and market equilibrium; others circling back on bad debt 75-110 bps and bankruptcy activity) and management's acknowledgment that "recent retailer bankruptcy announcements will result in occupancy pressure" while noting they've "been preparing for the last several quarters." This period's evidence cuts against it: record 94% total occupancy (up sequentially in a seasonally weak quarter), small-shop at 89.
CME · Q2 2022 → YESThe question is: Identify ONE well-defined DOUBT that has been weighing on the company, and see if the current period's operating evidence moves against that doubt. YES The standing doubt is the perceived risk that the legacy NEX Group businesses (BrokerTec and EBS) would continue to show range-bound revenue and fail to deliver meaningful growth despite a constructive macro backdrop, as directly raised by Alex Blostein. Management engages this concern head-on by recounting concrete operating evidence from 2Q: BrokerTec US treasuries ADV up 14% YoY, US repo up 25% YoY, EU repo up 14% YoY, plus $4.5 billion in new cross-sell volume from previously non-trading clients and record RV trading volumes of $2.4 billion; 90% of the migration to Globex is complete, with the remaining EBS migration also finished and system enhancements underway.
BXSL · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible in the transcript, and if this period's operating evidence moves against it. YES The standing doubt visible in the transcript is the skepticism that BXSL’s credit performance will be materially worse than the broader private-credit market because of its exposure to higher-rate environments and the “tails” of the portfolio (i.e., the small slice of companies whose interest-coverage ratios could fall below 1× when 5 % rates are stress-tested). Management itself flags this concern by noting that “it is less about averages… much more about the tails” and that investors keep asking about the percentage of the portfolio below 1× ICR. This quarter’s operating evidence directly counters that doubt: - 0.